2-BBB is created to develop medicines for the treatment of devastating brain diseases. We believe that we can transform the lives of those affected faster and more successful by combining known disease targets and compounds with established drug delivery systems united with safe targeting technology. This has led to two programs in clinical development for the treatment of brain cancer and neuro-inflammatory diseases.
Meet us at
2017, April 11: 2-BBB announces joint venture in Taiwan with TTY Biopharm on its acute MS relapse program 2B3-201
2017, March 28: Oncology Venture in-licenses 2-BBB’s Phase 2 product 2B3-101 for 2X Oncology’s pipeline
2017, March 28: Leidsch Dagblad: Doorbaak voor Leids biotechbedrijf; Chemo voor hersentumor